981 related articles for article (PubMed ID: 23324188)
1. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
Yang ZJ; Wei RJ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
[TBL] [Abstract][Full Text] [Related]
2. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
Yang ZJ; Liu ZC; Wei RJ; Li L
Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
[TBL] [Abstract][Full Text] [Related]
3. [Comprehensive staging surgery in treatment of malignant ovarian germ cell tumor].
Jin Y; Pan LY; Huang HF; Shen K; Wu M; Yang JX; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):826-30. PubMed ID: 16412329
[TBL] [Abstract][Full Text] [Related]
4. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
5. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of serum CA(125) level change during chemotherapy post-surgery in patients with advanced epithelial ovarian carcinoma].
Lan CY; Huang H; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):732-6. PubMed ID: 19087537
[TBL] [Abstract][Full Text] [Related]
7. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
Low JJ; Perrin LC; Crandon AJ; Hacker NF
Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
[TBL] [Abstract][Full Text] [Related]
8. [Multicenter randomized controlled clinical study for the operative treatment of malignant ovarian germ cell tumors].
Liu Q; Ding XL; Yang JX; Cao DY; Shen K; Lang JH; Zhang GN; Xin XY; Xie X; Zhang SL; Wu YM; Zhu GH; Wang J; Chen YL; Kong BH; Zheng JH
Zhonghua Fu Chan Ke Za Zhi; 2013 Mar; 48(3):188-92. PubMed ID: 23849941
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the effect of fertility-saving surgery on young patients with malignant ovarian tumors].
Xi MR; Hou MM; Cao ZY; Zhang CS; Peng ZL; Wang HJ; Zheng A
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):233-6. PubMed ID: 16759456
[TBL] [Abstract][Full Text] [Related]
10. [Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma].
Zhao XD; Zhang Q; Zhang Y
Ai Zheng; 2005 Aug; 24(8):1002-5. PubMed ID: 16086882
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
Li J; Yang W; Wu X
Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
[TBL] [Abstract][Full Text] [Related]
12. [Lymphadenectomy in the treatment of malignant ovarian germ cell tumor].
Jin Y; Pan LY; Huang HF; Shen K; Wu M; Yang JX; Lang JH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Dec; 27(6):743-8. PubMed ID: 16447650
[TBL] [Abstract][Full Text] [Related]
13. Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer.
Chang SJ; Bristow RE; Ryu HS
Ann Surg Oncol; 2012 Dec; 19(13):4059-67. PubMed ID: 22766983
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer.
Chang SJ; Bristow RE; Ryu HS
Gynecol Oncol; 2012 Sep; 126(3):381-6. PubMed ID: 22609747
[TBL] [Abstract][Full Text] [Related]
15. Malignant ovarian germ cell tumors: a single-institution experience.
Cicin I; Eralp Y; Saip P; Ayan I; Kebudi R; Iyibozkurt C; Tuzlali S; Gorgun O; Topuz E
Am J Clin Oncol; 2009 Apr; 32(2):191-6. PubMed ID: 19307952
[TBL] [Abstract][Full Text] [Related]
16. Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes.
Tangjitgamol S; Hanprasertpong J; Manusirivithaya S; Wootipoom V; Thavaramara T; Buhachat R
Acta Obstet Gynecol Scand; 2010; 89(2):182-9. PubMed ID: 19961281
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.
Levesque MA; Katsaros D; Massobrio M; Genta F; Yu H; Richiardi G; Fracchioli S; Durando A; Arisio R; Diamandis EP
Clin Cancer Res; 2000 Aug; 6(8):3260-70. PubMed ID: 10955812
[TBL] [Abstract][Full Text] [Related]
18. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
[TBL] [Abstract][Full Text] [Related]
20. [Results of fertility preserving operations in malignant ovarian tumors].
Kleine W
Zentralbl Gynakol; 1996; 118(6):317-21. PubMed ID: 8768006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
